Involvement of nitric oxide in lipopolysaccharide induced anorexia

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 1, 2010, Pages 112-120

  Riediger, Thomas ^a   Cordani, Caroline ^a   Potes, Catarina Soares ^a   Lutz, Thomas A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Arcuate nucleus; Food intake; Hypothalamus; Inflammation; Nitric oxide synthase

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; STAT3 PROTEIN;

ADIPSIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENERGY EXPENDITURE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANOREXIA; ARCUATE NUCLEUS; IMINES; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 77957751003     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.04.015     Document Type: Article

References (57)

1. Argiles J.M., Lopez-Soriano F.J. The role of cytokines in cancer cachexia. Med Res Rev 1999, 19:223-248.
2. Arimoto T., Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol Dis 2003, 12:35-45.
3. Banks W.A. Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier. Nutrition 2001, 17:434-437.
4. Banks W.A., Kastin A.J. Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci 1996, 59:1923-1943.
5. Baumann H., Gauldie J. The acute phase response. Immunol Today 1994, 15:74-80.
6. Becskei C., Riediger T., Hernadfalvy N., Arsenijevic D., Lutz T.A., Langhans W. Inhibitory effects of lipopolysaccharide on hypothalamic nuclei implicated in the control of food intake. Brain Behav Immun 2008, 22:56-64.
7. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000, 12:20-26.
8. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
9. Cutler D.J., Morris R., Evans M.L., Leslie R.A., Arch J.R., Williams G. Orexin-A immunoreactive neurons in the rat hypothalamus do not contain neuronal nitric oxide synthase (nNOS). Peptides 2001, 22:123-128.
10. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J., et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997, 272:4959-4963.
11. Gautron L., Lafon P., Chaigniau M., Tramu G., Laye S. Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge. Neuroscience 2002, 112:717-729.
12. Gayle D., Ilyin S.E., Plata-Salaman C.R. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Res Bull 1997, 44:311-317.
13. Hakansson M.L., Meister B. Transcription factor STAT3 in leptin target neurons of the rat hypothalamus. Neuroendocrinology 1998, 68:420-427.
14. Harre E.M., Roth J., Pehl U., Kueth M., Gerstberger R., Hubschle T. Selected contribution: role of IL-6 in LPS-induced nuclear STAT3 translocation in sensory circumventricular organs during fever in rats. J Appl Physiol 2002, 92:2657-2666.
15. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988, 12:123-137.
16. Imada K., Leonard W.J. The Jak-STAT pathway. Mol Immunol 2000, 37:1-11.
17. Kleinert H., Pautz A., Linker K., Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004, 500:255-266.
18. Kotler D.P. Cachexia. Ann Intern Med 2000, 133:622-634.
19. Langhans W. Anorexia of infection: current prospects. Nutrition 2000, 16:996-1005.
20. Langhans W. Anorexia during disease. Neurobiology of Fluid and Food Intake 2004, 347-379. Kluwer Academic/Plenum Publishers, New York. E. Stricker, S.C. Woods (Eds.).
21. Langhans W. Signals generating anorexia during acute illness. Proc Nutr Soc 2007, 66:321-330.
22. Langhans W., Balkowski G., Savoldelli D. Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide. Am J Physiol 1991, 261:R659-R664.
23. Langhans W., Savoldelli D., Weingarten S. Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1 beta. Physiol Behav 1993, 53:643-649.
24. Matthys P., Billiau A. Cytokines and cachexia. Nutrition 1997, 13:763-770.
25. McDonald L.J., Murad F. Nitric oxide and cyclic GMP signaling. Proceedings of the Society for Experimental Biology and Medicine. Soc Exp Biol Med (New York, N.Y.) 1996, 211:1-6.
26. McNamara M.J., Alexander H.R., Norton J.A. Cytokines and their role in the pathophysiology of cancer cachexia. Jpen 1992, 16:50S-55S.
27. Moncada S., Palmer R., Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
28. Morley J.E., Flood J.F. Evidence that nitric oxide modulates food intake in mice. Life Sci 1991, 49:707-711.
29. Morley J.E., Flood J.F. Competitive antagonism of nitric oxide synthetase causes weight loss in mice. Life Sci 1992, 51:1285-1289.
30. Morley J.E., Flood J.F. Effect of competitive antagonism of NO synthetase on weight and food intake in obese and diabetic mice. Am J Physiol 1994, 266:R164-R168.
31. Morrison C.D., White C.L., Wang Z., Lee S.Y., Lawrence D.S., Cefalu W.T., et al. Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology 2007, 148:433-440.
32. Nicolaidis S., Fitzsimons J. La dependance de la prise d'eau induit par l'angiotensin II envers la fonction vasomotorice cerebrale locale chez le rat. CR Acad Soc Paris 1975, 1417-1420.
33. Parmentier S., Bohme G.A., Lerouet D., Damour D., Stutzmann J.M., Margaill I., et al. Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br J Pharmacol 1999, 127:546-552.
34. Parrott R.F., Vellucci S.V., Lloyd D.M. Effects of intravenous nitric oxide inhibitors on endotoxin-induced fever in prepubertal pigs. Gen Pharmacol 1998, 31:371-376.
35. Perez-Rodriguez R., Roncero C., Olivan A.M., Gonzalez M.P., Oset-Gasque M.J. Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: involvement of nNOS, iNOS, and NFkappaB. J Neurochem 2009, 108:1083-1096.
36. Plata-Salaman C.R. Anorexia during acute and chronic disease. Nutrition 1996, 12:69-78.
37. Rauch M., Schmid H.A., de Vente J., Simon E. Electrophysiological and immunocytochemical evidence for a cGMP-mediated inhibition of subfornical organ neurons by nitric oxide. J Neurosci 1997, 17:363-371.
38. Reyes T.M., Sawchenko P.E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J Neurosci 2002, 22:5091-5099.
39. Riediger T., Giannini P., Erguven E., Lutz T. Nitric oxide directly inhibits ghrelin-activated neurons of the arcuate nucleus. Brain Res 2006, 1125:37-45.
40. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. Faseb J 1994, 8:217-225.
41. Rietschel E.T., Schletter J., Weidemann B., El-Samalouti V., Mattern T., Zahringer U., et al. Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation. Microb Drug Resist 1998, 4:37-44.
42. Roth J., Storr B., Voigt K., Zeisberger E. Inhibition of nitric oxide synthase attenuates lipopolysaccharide-induced fever without reduction of circulating cytokines in guinea-pigs. Pflugers Arch 1998, 436:858-862.
43. Roth J., Storr B., Goldbach J., Voigt K., Zeisberger E. Dose-dependent attenuation of lipopolysaccharide-fever by inhibitors of inducible nitric oxide-synthase in guinea pigs. Eur J Pharmacol 1999, 383:177-187.
44. Rummel C., Voss T., Matsumura K., Korte S., Gerstberger R., Roth J., et al. Nuclear STAT3 translocation in guinea pig and rat brain endothelium during systemic challenge with lipopolysaccharide and interleukin-6. J Comp Neurol 2005, 491:1-14.
45. Samavati L., Rastogi R., Du W., Huttemann M., Fite A., Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol 2009, 46:1867-1877.
46. Schmidt H., Lohmann S., Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993, 1178:153-175.
47. Singh A., Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats?. Toxicology 2004, 201:197-207.
48. Soszynski D. The inhibition of nitric oxide synthase suppresses LPS- and psychological-stress-induced fever in rats. Physiol Behav 2001, 72:65-72.
49. Squadrito F., Calapai G., Cucinotta D., Altavilla D., Zingarelli B., Ioculano M., et al. Anorectic activity of NG-nitro-l-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. Eur J Pharmacol 1993, 230:125-128.
50. Squadrito F., Calapai G., Altavilla D., Cucinotta D., Zingarelli B., Arcoraci V., et al. Central serotoninergic system involvement in the anorexia induced by NG-nitro-l-arginine, an inhibitor of nitric oxide synthase. Eur J Pharmacol 1994, 255:51-55.
51. Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res/Acad Sci Bohemoslov 2008, 57:813-825.
52. Turrin N.P., Gayle D., Ilyin S.E., Flynn M.C., Langhans W., Schwartz G.J., et al. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull 2001, 54:443-453.
53. Vitkovic L., Bockaert J., Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain?. J Neurochem 2000, 74:457-471.
54. Wang W., Svanberg E., Delbro D., Lundholm K. NOS isoenzyme content in brain nuclei as related to food intake in experimental cancer cachexia. Brain Res Mol Brain Res 2005, 134:205-214.
55. Wong M., Rettori V., al-Shekhlee A., Bongiorno P., Canteros G., McCann S., et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med 1996, 2:581-584.
56. Wong M.L., Rettori V., al-Shekhlee A., Bongiorno P.B., Canteros G., McCann S.M., et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med 1996, 2:581-584.
57. Zhong Z., Wen Z., Darnell J.E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994, 264:95-98.